Edition:
United Kingdom

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

115.36USD
25 Sep 2018
Change (% chg)

$1.37 (+1.20%)
Prev Close
$113.99
Open
$114.36
Day's High
$115.52
Day's Low
$114.33
Volume
223,816
Avg. Vol
187,773
52-wk High
$115.52
52-wk Low
$75.28

Latest Key Developments (Source: Significant Developments)

Resmed Q4 Non-GAAP Earnings Per Share $0.95
Thursday, 2 Aug 2018 

Resmed Inc ::. ANNOUNCES RESULTS FOR THE FOURTH QUARTER OF FISCAL YEAR 2018.Q4 NON-GAAP EARNINGS PER SHARE $0.95.Q4 GAAP EARNINGS PER SHARE $0.76.Q4 REVENUE $623.6 MILLION VERSUS I/B/E/S VIEW $623.2 MILLION.Q4 EARNINGS PER SHARE VIEW $0.95 -- THOMSON REUTERS I/B/E/S.QUARTERLY DIVIDEND INCREASED BY 6% TO $0.37 PER SHARE.  Full Article

Resmed, Verily To Form Joint Venture To Help Reach Millions Of Untreated Sleep Apnea Sufferers
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Resmed Inc ::RESMED, VERILY TO FORM JOINT VENTURE TO HELP REACH MILLIONS OF UNTREATED SLEEP APNEA SUFFERERS.RESMED INC - JOINT VENTURE WILL OPERATE AS A SEPARATE VENTURE FROM RESMED AND VERILY.RESMED - CO, VERILY, AN ALPHABET COMPANY, ANNOUNCED AGREEMENT TO FORM NEW JV.  Full Article

Resmed Inc To Acquire Healthcarefirst
Tuesday, 29 May 2018 

May 29 (Reuters) - Resmed Inc ::RESMED TO ACQUIRE HEALTHCAREFIRST, A CLOUD-BASED SOFTWARE AND SERVICES PROVIDER FOR HOME HEALTH AND HOSPICE AGENCIES.RESMED INC - TRANSACTION'S FINANCIAL TERMS WERE NOT DISCLOSED.  Full Article

Fisher & Paykel Healthcare Corporation ‍says wins patent case against ResMed in UK court​
Sunday, 12 Nov 2017 

Nov 13 (Reuters) - Fisher & Paykel Healthcare Corporation Ltd :‍Wins patent case against ResMed in UK court.Patent found invalid, ‍subject to appeal, European patent will be revoked in UK​.  Full Article

Resmed Inc reports Q1 earnings $0.60/shr
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Resmed Inc :Resmed Inc. Announces results for the first quarter of fiscal year 2018.Q1 GAAP earnings per share $0.60.Q1 revenue $523.7 million versus I/B/E/S view $505.6 million.Q1 earnings per share view $0.66 -- Thomson Reuters I/B/E/S.  Full Article

RESMED WINS GERMAN PATENT INFRINGEMENT CASE BROUGHT BY FISHER & PAYKEL
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Resmed Inc ::RESMED WINS GERMAN PATENT INFRINGEMENT CASE BROUGHT BY FISHER & PAYKEL.MUNICH DISTRICT COURT DECIDED CO'S AIRSENSE 10, AIRCURVE 10, LUMIS AND HUMIDIFIERS DO NOT INFRINGE FISHER & PAYKEL GERMAN UTILITY MODEL​.‍RULING IN GERMANY HAS NO IMPACT ON RESMED, FISHER & PAYKEL'S PATENT INFRINGEMENT LITIGATION IN OTHER JURISDICTIONS​.  Full Article

EU mergers and takeovers (Sept 25)

BRUSSELS, Sept 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process: